Dr. Carol Lin is a CHOC Children’s Specialist in pediatric oncology at the Hyundai Cancer Institute. She is board certified in pediatrics and pediatric hematology/oncology. Her clinical interests include Acute Lymphoblastic Leukemia (ALL), Relapsed/Refractory leukemia, Hodgkin’s and Non-Hodgkin’s Lymphomas, After Cancer Treatment Survivorship (ACTS), and Neurofibromatosis (Plexiform neurofibromatosis/Optic Pathway Glioma).
Prior to joining CHOC Children’s, Dr. Lin attended medical school at SUNY Upstate Medical University. She completed both her pediatric residency and pediatric hematology/oncology fellowship at CHOC Children’s Hospital. She is an integral part of multiple oncology teams, including Leukemia/Lymphoma, After Cancer Treatment Survivorship, and Neurofibromatosis Program.
Dr. Lin’s research focus includes Acute Lymphoblastic Leukemia, cancer survivorship and the long term effects of disease and treatments.